Idiopathic Pulmonary Fibrosis Disease - Global Clinical Trials Review, H2, 2020
Idiopathic Pulmonary Fibrosis Disease - Global Clinical Trials Review, H2, 2020
.png "REMAP-ILD: The future of clinical trials in pulmonary fibrosis – Action for Pulmonary Fibrosis")
REMAP-ILD: The future of clinical trials in pulmonary fibrosis – Action for Pulmonary Fibrosis
Selected recent clinical trials in idiopathic pulmonary fibrosis | Download Table
Phase IV IPF Clinical Trials | ILD Collaborative
Clinical Trial for Idiopathic Pulmonary Fibrosis - Responsum Health
Qureight announces world's first digital biomarker for lung fibrosis will 'transform' clinical trials - PMLiVE
Recent Clinical Trials on Idiopathic Pulmonary Fibrosis | Download Table
Idiopathic Pulmonary Fibrosis (IPF) - Renstar Medical Research
Trial of a Preferential Phosphodiesterase 4B Inhibitor for Idiopathic Pulmonary Fibrosis | NEJM
Ongoing challenges in pulmonary fibrosis and insights from the nintedanib clinical programme | Respiratory Research | Full Text
Global Idiopathic Pulmonary Fibrosis Clinical Trial Pipeline Highlights - 2022
Overview of Idiopathic Pulmonary Fibrosis, Evidence-Based Guidelines, and Recent Developments in the Treatment Landscape
![Top 10 IPF Clinical Trials [2023 Studies] | Power](https://pwr-og-img.withpower.com/IPF%20research%20studies%20recruiting%20patients%20in%202023%20need%20your%20help.%20Receive%20premium%20care%20&%20cutting%20edge%20treatments%20by%20enrolling%20in%20idiopathic%20pulmonary%20fibrosis%20clinical%20trials%20today..png?md=1 "Top 10 IPF Clinical Trials [2023 Studies] | Power")
Top 10 IPF Clinical Trials [2023 Studies] | Power
Idiopathic pulmonary fibrosis: lessons from clinical trials over the past 25 years | European Respiratory Society
Ongoing clinical trials in idiopathic pulmonary fibrosis | Download Table
Idiopathic pulmonary fibrosis: current challenges and future perspectives | European Respiratory Society
Clinical Trials for Pulmonary Fibrosis: How Can Participation Be Improved? - Xtalks
Effect of pirfenidone on mortality: pooled analyses and meta-analyses of clinical trials in idiopathic pulmonary fibrosis - The Lancet Respiratory Medicine
Enrollment now complete for Phase 3 trial of pamrevlumab in IPF | Results from FibroGen study ZEPHYRUS-2 expected in mid-2024 | Pulmonary Fibrosis News
